Also on

  • Also on

    • Leaders of Analysis Group’s Health Care practice have been consistently recognized as industry leaders at leading international conferences and have also been involved in significant trends in health care litigation. 


      Researchers from Analysis Group's Health Care practice presented one educational symposium and one workshop, and exhibited 24 posters, at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 20th Annual International Meeting. Three posters supported by Analysis Group researchers received finalist ribbons. The research, covering tuberous sclerosis complex, obesity, and migraines, involved Managing Principals Mei Sheng Duh and Edward Tuttle, Principal Howard Birnbaum, Vice Presidents Noam Kirson and Francis Vekeman, and Managers Rajeev Ayyagari and Amie Shei.  


      In August 2015, a group of prominent economists that included senior staff members Bruce Stangle, Paul Greenberg, Pierre Cremieux, and George Kosicki, and academic economists James Hughes, Keith Hylton, Edward Snyder, and Michael Wohlgenant filed an amicus curiae brief regarding issues in the antitrust treatment of pharmaceutical patent infringement settlements. In January 2015, senior firm members Bruce Stangle and Paul Greenberg, and academic economists Henry Grabowski, James Hughes, John Rizzo, Edward Snyder, and Michael Wohlgenant, filed an amicus curiae brief regarding a pharmaceutical manufacturer’s freedom to withdraw a branded product from the market prior to generic entry.